Deucravacitinib in Plaque Psoriasis: Laboratory Parameters Through 4 Years of Treatment in the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s419, 2024. DOI: 10.25251/skin.8.supp.419. Disponível em: https://skin.dermsquared.com/skin/article/view/3086. Acesso em: 20 apr. 2026.